Equities

MSP Recovery Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CN50:MUN

MSP Recovery Inc

Actions
  • Price (EUR)0.278
  • Today's Change0.00 / 0.00%
  • Shares traded2.00k
  • 1 Year change--
  • Beta0.5720
Data delayed at least 15 minutes, as of Dec 09 2025 07:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MSP Recovery, Inc. is a healthcare reimbursement recovery and data analytics company, providing historical and near-real-time solutions for payers, providers, and patients. It is disrupting the antiquated healthcare reimbursement system by discovering losses and recovering improper payments for Medicare, Medicaid, and commercial health insurers, and innovating technologies and comprehensive services for multiple industries, including healthcare and legal. Its access to large volumes of data, sophisticated data analytics platforms, and advanced technology provide an opportunity to discover and recover improper healthcare claims payments. It has developed Algorithms to identify waste, fraud, and abuse in the Medicare, Medicaid, and commercial health insurance sectors. It analyzes historical medical claims data to identify recoverable opportunities. It has developed a technologically advanced Electronic Health Record platform that streamlines the retrieval and analysis of medical data.

  • Revenue in USD (TTM)9.81m
  • Net income in USD-719.22m
  • Incorporated2019
  • Employees78.00
  • Location
    MSP Recovery Inc3150 Sw 38Th Avenue, Suite 1100MIAMI 33146United StatesUSA
  • Phone+1 (305) 614-2222
  • Fax+1 (302) 655-5049
  • Websitehttps://www.msprecovery.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.